Yuan Cheng, Legal Representative

Title: The Innovations of Yuan Cheng, Legal Representative

Introduction

Yuan Cheng is a notable inventor and legal representative based in Newbury Park, California. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target the CCR5 chemokine receptor. His work is crucial in the ongoing fight against HIV and AIDS.

Latest Patents

Yuan Cheng holds a patent for "Pyrrolidine modulators of CCR5 chemokine receptor activity." This patent describes pyrrolidine compounds that serve as modulators of CCR5 chemokine receptor activity. These compounds are particularly useful in the prevention or treatment of HIV infections and the treatment of AIDS. The patent outlines the potential use of these compounds, including their application as pharmaceutically acceptable salts or as ingredients in pharmaceutical compositions, often in combination with other antivirals, immunomodulators, antibiotics, or vaccines.

Career Highlights

Yuan Cheng is currently employed at Merck & Company, Inc., a leading global healthcare company. His role as a legal representative allows him to bridge the gap between scientific innovation and legal protection, ensuring that groundbreaking discoveries are adequately safeguarded.

Collaborations

Yuan Cheng has collaborated with esteemed colleagues such as Jeffrey John Hale and Charles G Caldwell. These partnerships enhance the research and development efforts within the pharmaceutical industry, contributing to advancements in medical treatments.

Conclusion

Yuan Cheng's work exemplifies the intersection of innovation and legal expertise in the pharmaceutical field. His contributions to the development of CCR5 modulators are vital in the ongoing battle against HIV and AIDS. His career at Merck & Company, Inc. highlights the importance of collaboration in achieving significant medical advancements.